Actively Recruiting
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Led by Beijing Friendship Hospital · Updated on 2024-01-30
600
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying patients with papillary thyroid carcinoma PTC who have undergone thermal ablation at a hospital since February 2023. The study aims to analyze factors that may influence the recurrence of PTC after this treatment. Data collected include demographic information, ultrasound results, laboratory tests, and thyroid disease-related scales measuring fatigue, depression, and stress. The study involves no additional interventions beyond the thermal ablation already received by participants. Ultrasound and pathology are used to confirm diagnosis and characteristics of the thyroid nodules before treatment. Follow-up occurs for one to five years to observe the recurrence of PTC. Participants provide demographic and medical data before and after ablation. Researchers monitor recurrence using ultrasound and assess thyroid-related symptoms through questionnaires. The primary outcome measured is the rate of PTC recurrence over one to five years. The study is observational, with no experimental treatment assigned, and participants are monitored over time to better understand recurrence risks.
CONDITIONS
Brief Title
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Provide informed consent
- Ultrasonography shows a single malignant nodule with a maximum diameter of 1 cm
- Nodule is at least 2 mm from the capsule
- No lymph node or other extra-glandular metastasis in the neck
- Papillary thyroid carcinoma confirmed by fine needle puncture pathology
- Patients who do not meet the no metastasis criterion but strongly request thermal ablation after being informed of recurrence risks and are clinically assessed as technically suitable
You will not qualify if you...
- Pregnant or lactating patients
- Patients with other malignant tumors unsuitable for ablation by clinical evaluation
- Patients who cannot tolerate surgery
- Patients with cognitive impairments or other conditions preventing accurate completion of thyroid-related questionnaires
Research Team
X
Xianquan Shi, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here